Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -13.91% is 260% below its 5-year average of -3.87%, around the middle of its 5-year range (-31.44%–10.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 416.49% below its 12-month average of 4.39%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-13.91%
NET PROFIT MARGIN AVG TTM
4.39%
NET PROFIT MARGIN AVG 3Y
-1.69%
NET PROFIT MARGIN AVG 5Y
-3.87%
NET PROFIT MARGIN AVG 10Y
-1.77%
NET PROFIT MARGIN AVG 15Y
3.17%
NET PROFIT MARGIN AVG 20Y
6.23%
CURRENT VS TTM AVG
-416.49%
CURRENT VS 3Y AVG
-721.22%
CURRENT VS 5Y AVG
-259.67%
CURRENT VS 10Y AVG
-686.80%
CURRENT VS 15Y AVG
-538.91%
CURRENT VS 20Y AVG
-323.17%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-251.07%
vs the sector median at left
Teva Pharmaceutical Industries Limited
Market Cap
$42.82B
Net Profit Margin
-13.91%
TTM Avg
4.39%
3Y Avg
-1.69%
5Y Avg
-3.87%
Market Cap
$43.10B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
Market Cap
$43.39B
Net Profit Margin
19.53%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$43.62B
Net Profit Margin
25.03%
TTM Avg
23.70%
3Y Avg
22.66%
5Y Avg
22.55%
Market Cap
$34.14B
Net Profit Margin
20.12%
TTM Avg
16.12%
3Y Avg
14.73%
5Y Avg
15.57%
Market Cap
$51.97B
Net Profit Margin
15.43%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | $42.82B | -13.91% | 4.39% | -1.69% | -3.87% |
| IQVIA Holdings Inc. (IQV)vs › | $43.10B | 8.10% | 8.63% | 8.47% | 7.22% |
| Agilent Technologies, Inc. (A)vs › | $43.39B | 19.53% | 19.27% | 18.75% | 17.94% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.62B | 25.03% | 23.70% | 22.66% | 22.55% |
| Humana Inc. (HUM)vs › | $46.95B | 0.88% | 0.97% | 1.82% | 2.53% |
| Alcon Inc. (ALC)vs › | $34.95B | 5.95% | 9.84% | 8.46% | 5.10% |
| ResMed Inc. (RMD)vs › | $34.73B | 26.94% | 27.08% | 24.30% | 22.30% |
| DexCom, Inc. (DXCM)vs › | $34.14B | 20.12% | 16.12% | 14.73% | 15.57% |
| Edwards Lifesciences Corporation (EW)vs › | $51.97B | 15.43% | 47.22% | 37.68% | 33.03% |
| Becton, Dickinson and Company (BDX)vs › | $52.22B | 4.52% | 8.06% | 8.30% | 8.27% |
Operating Margin
11.4%
Net Profit Margin
-13.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -13.91% |
| 2026-03-31 | 9.27% |
| 2025-12-31 | 10.19% |
| 2025-09-30 | 9.67% |
| 2025-06-30 | 6.75% |
| 2025-03-31 | 5.50% |
| 2024-12-31 | -5.13% |
| 2024-09-30 | -10.09% |
| 2024-06-30 | -20.32% |
| 2024-03-31 | -3.64% |
| 2023-12-31 | 10.39% |
| 2023-09-30 | 1.79% |
| 2023-06-30 | -22.49% |
| 2023-03-31 | -6.01% |
| 2022-12-31 | -31.44% |
| 2022-09-30 | 1.56% |
| 2022-06-30 | -6.13% |
| 2022-03-31 | -26.09% |
| 2021-12-31 | -3.88% |
| 2021-09-30 | 7.51% |
| 2021-06-30 | 5.29% |
| 2021-03-31 | 1.93% |
| 2020-12-31 | 3.37% |
| 2020-09-30 | -109.33% |
| 2020-06-30 | 3.62% |
| 2020-03-31 | 1.58% |
| 2019-12-31 | 2.44% |
| 2019-09-30 | -7.36% |
| 2019-06-30 | -15.89% |
| 2019-03-31 | -2.44% |
| 2018-12-31 | -63.30% |
| 2018-09-30 | -4.59% |
| 2018-06-30 | -3.74% |
| 2018-03-31 | 20.83% |
| 2017-12-31 | -211.30% |
| 2017-09-30 | 9.45% |
| 2017-06-30 | -104.99% |
| 2017-03-31 | 10.30% |
| 2016-12-31 | -14.99% |
| 2016-09-30 | 6.26% |
| 2016-06-30 | 5.04% |
| 2016-03-31 | 11.85% |
| 2015-12-31 | 10.24% |
| 2015-09-30 | 2.14% |
| 2015-06-30 | 10.85% |
| 2015-03-31 | 8.95% |
| 2014-12-31 | 13.29% |
| 2014-09-30 | 17.32% |
| 2014-06-30 | 14.83% |
| 2014-03-31 | 14.88% |
| 2013-12-31 | 7.00% |
| 2013-09-30 | 14.05% |
| 2013-06-30 | -9.18% |
| 2013-03-31 | 12.85% |
| 2012-12-31 | 6.10% |
| 2012-09-30 | -1.59% |
| 2012-06-30 | 17.28% |
| 2012-03-31 | 16.84% |
| 2011-12-31 | 8.91% |
| 2011-09-30 | 21.09% |
| 2011-06-30 | 13.68% |
| 2011-03-31 | 18.65% |
| 2010-12-31 | 17.45% |
| 2010-09-30 | 24.71% |
| 2010-06-30 | 20.97% |
| 2010-03-31 | 19.52% |
| 2009-12-31 | 9.97% |
| 2009-09-30 | 18.28% |
| 2009-06-30 | 15.32% |
| 2009-03-31 | 14.33% |
| 2008-12-31 | -24.16% |
| 2008-09-30 | 22.41% |
| 2008-06-30 | 19.09% |
| 2008-03-31 | 5.72% |
| 2007-12-31 | 22.13% |
| 2007-09-30 | 22.19% |
| 2007-06-30 | 21.58% |
| 2007-03-31 | 16.44% |
| 2006-12-31 | 20.19% |
| 2006-09-30 | 26.53% |
| 2006-06-30 | 22.48% |
| 2006-03-31 | -60.31% |
| 2005-12-31 | 21.76% |
| 2005-09-30 | 20.28% |
| 2005-06-30 | 19.65% |
| 2005-03-31 | 19.86% |
| 2004-12-31 | 21.08% |
| 2004-09-30 | 20.16% |
| 2004-06-30 | 19.51% |
| 2004-03-31 | -40.67% |
| 2003-12-31 | 19.78% |
| 2003-09-30 | 19.27% |
| 2003-06-30 | 27.52% |
| 2003-03-31 | 18.18% |
| 2002-12-31 | 17.72% |
| 2002-09-30 | 15.25% |
